Merck Sells Consumer Business, Suggests No Hep C Price War with Gilead
moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]
GILD
Gilead Science – Solvadi’s Pricing In A New Perspective
moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]
Gilead Is Set To Grow
moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]
Earnings Beat at Pharmacyclics, Guidance Pulls Down Stock
moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]
Pfizer Tops on Q1 Earnings, Generics Hit Revs
moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]
Should You Invest in Gilead Sciences, Inc. Today?
moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]
4:09 pm Gilead Sciences beats by $0.58, beats on revs; reiterates FY14 guidance
moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]
[$$] Gilead Sciences’ Earnings Triple on New Hepatitis Drug
[at The Wall Street Journal] – Gilead Sciences reported nearly $2.3 billion in first-quarter sales for its new hepatitis C treatment Sovaldi in what is believed to be the best-selling prescription drug launch in history. moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to […]
Asia shares gain ahead of HSBC China flash PMI
moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]
[$$] Gilead Sciences’ Earnings Triple on New Hepatitis Drug
[at The Wall Street Journal] – Gilead Sciences reported nearly $2.3 billion in first-quarter sales for its new hepatitis C treatment Sovaldi in what is believed to be the best-selling prescription drug launch in history. moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to […]
